Skip to main content

Vir Biotechnology, Inc.

VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001706431

No open-market purchases or sales by Vir Biotechnology, Inc. insiders were filed in the last 90 days; 237 institutions reported holding it in 13F filings for Q2 2026, worth $1.49B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Vir Biotechnology, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Vir Biotechnology, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Vir Biotechnology, Inc.
NameTitleLast reported holdingLast filingFilings, past year
More Robert JDirector517,917IndirectAug 12, 20262
Coughlin TimothyDirector16,000Jun 10, 20261
Napolitano JanetDirector21,216Jun 2, 20262
Sabatini BrentSVP, Chief Accounting Officer61,902Jun 2, 20265
Bischofberger Norbert WDirector21,333May 28, 20261
Hatfield Jeffrey S.Director39,806May 28, 20261
Sigal Charles ElliottDirector39,806May 28, 20261
Farid RamyDirector32,000May 28, 20261
Sato Vicki LDirector1,078,391May 4, 20269
De Backer MariannePresident and CEO286,650IndirectApr 30, 20264
O'Byrne JasonEVP & Chief Financial Officer2,500IndirectMar 23, 20264
Eisner MarkEVP and Chief Medical Officer154,024Feb 26, 20262
de Verneuil VaninaEVP, General Counsel, Corp Sec112,982Feb 26, 20264
SB Investment Advisers (UK) Ltd10% Owner13,728,924IndirectDec 3, 202511
Softbank Vision Fund (Aiv M1) L.P.10% Owner13,728,924IndirectDec 3, 202511
SVF Endurance (Cayman) Ltd10% Owner13,728,924IndirectDec 3, 202511
Ramasastry SairaDirector22,619Jun 2, 20250
Scangos George ADirector698,239Feb 25, 20250
Hanly Ann M.EVP & Chief Technology Officer117,901Feb 25, 20250
Nelsen RobertDirector584,148Jun 3, 20240
Lee SungEVP & Chief Financial Officer100,492Mar 28, 20240
Pang PhillipEVP & Chief Medical Officer250,111Feb 26, 20240
Rice Steven J.Chief Administrative Officer106,840Jun 2, 20230
Sharp Phillip ADirector121,174May 24, 20230
Perez Robert JDirector15,806May 24, 20230
Friedl-Naderer JohannaEVP & Chief Operating Officer148,518Mar 7, 20230
Horn HowardCFO230,712Feb 24, 20230
Crandell Keith10% Owner61,160IndirectSep 7, 20220
Bybee Clinton10% Owner61,160IndirectSep 7, 20220
ARCH Venture Fund IX, L.P.10% Owner61,160IndirectSep 7, 20220
ARCH Venture Fund IX Overage, L.P.10% Owner61,160IndirectSep 7, 20220
ARCH Venture Partners IX Overage, L.P.10% Owner61,160IndirectSep 7, 20220
ARCH Venture Partners IX, L.P.10% Owner61,160IndirectSep 7, 20220
ARCH Venture Partners IX, LLC10% Owner61,160IndirectSep 7, 20220
Virgin HerbertEVP, Research & CSO262,500Aug 10, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 19, 2025 (view filing)Feb 181 dayScangos George ADirectorSSale−11.0K$9.81−$107.6K−1.5%708.3K after10b5-1
Feb 14, 2025 (view filing)Feb 131 daySabatini BrentSVP, Chief Accounting OfficerSSale−1.56K$9.15−$14.3K−5.3%28.2K after10b5-1
Jan 8, 2025 (view filing)Jan 8Same daySato Vicki LDirectorSSale−11.0K$12.52−$137.2K−0.8%1.31M after10b5-1
Dec 4, 2024 (view filing)Dec 22 daysde Verneuil VaninaEVP and General CounselSSale−76$8.22−$624.72−0.1%57.0K after
Nov 7, 2024 (view filing)Nov 61 dayde Verneuil VaninaEVP and General CounselSSale−4.40K$10.11−$44.5K−7.2%57.0K after10b5-1
Nov 5, 2024 (view filing)Nov 1-54 daysde Verneuil VaninaEVP and General CounselSSale−3.75K$8.62−$32.3K−5.8%61.4K after2 lots10b5-1
Sep 10, 2024 (view filing)Sep 91 dayNapolitano JanetDirectorSSale−12.2K$7.80−$95.1K−51.2%11.6K after10b5-1
Jun 12, 2024 (view filing)Jun 111 dayRamasastry SairaDirectorSSale−4.00K$10.95−$43.8K−21.5%14.6K after
Apr 4, 2024 (view filing)Apr 31 dayDe Backer MarianneChief Executive OfficerSSale−73.0K$9.46−$690.5K−9.7%678.5K after10b5-1
Apr 2, 2024 (view filing)Apr 11 dayHanly Ann M.EVP & Chief Technology OfficerSSale−2.71K$10.05−$27.2K−2.0%132.1K after10b5-1
Mar 28, 2024 (view filing)Mar 271 dayLee SungEVP & Chief Financial OfficerSSale−6.01K$9.89−$59.4K−5.6%100.5K after
Feb 26, 2024 (view filing)Feb 224 daysHanly Ann M.EVP & Chief Technology OfficerSSale−12.3K$10.05−$123.6K−8.4%134.8K after10b5-1
Feb 26, 2024 (view filing)Feb 224 daysPang PhillipEVP & Chief Medical OfficerSSale−14.6K$10.05−$146.4K−5.5%250.1K after10b5-1
Feb 26, 2024 (view filing)Feb 22-264 daysScangos George ADirectorSSale−27.8K$11.07−$307.2K−19.7%113.0K after2 lots10b5-1
Feb 20, 2024 (view filing)Feb 16-204 daysScangos George ADirectorSSale−27.8K$10.23−$283.8K−16.5%140.7K after2 lots10b5-1
Feb 16, 2024 (view filing)Feb 16Same dayPang PhillipEVP & Chief Medical OfficerSSale−3.32K$10.24−$34.0K−1.2%264.7K after10b5-1
Jul 5, 2023 (view filing)9:00 PM ETJun 305 daysSB Investment Advisers (UK) Ltd and 2 others10% OwnerSSale−700$25.11−$17.6K0.0%16.7M after
Jul 3, 2023 (view filing)Jun 303 daysSato Vicki LDirectorSSale−18.0K$24.66−$443.9K−1.3%1.32M after10b5-1
Jun 30, 2023 (view filing)9:00 PM ETJun 28-292 daysSB Investment Advisers (UK) Ltd and 2 others10% OwnerSSale−97.0K$25.17−$2.44M−0.6%16.7M after2 lots
Jun 22, 2023 (view filing)9:00 PM ETJun 202 daysSB Investment Advisers (UK) Ltd and 2 others10% OwnerSSale−9.90K$25.18−$249.3K−0.1%16.8M after
Jun 20, 2023 (view filing)9:00 PM ETJun 15-165 daysSB Investment Advisers (UK) Ltd and 2 others10% OwnerSSale−183.3K$25.56−$4.69M−1.1%16.8M after4 lots
Jun 15, 2023 (view filing)9:00 PM ETJun 13-142 daysSB Investment Advisers (UK) Ltd and 2 others10% OwnerSSale−164.1K$26.75−$4.39M−1.0%17.0M after4 lots
Jun 8, 2023 (view filing)Jun 71 dayPang PhillipChief Medical OfficerSSale−5.00K$25.95−$129.8K−2.6%188.0K after10b5-1
Jun 6, 2023 (view filing)9:00 PM ETJun 2-54 daysSB Investment Advisers (UK) Ltd and 2 others10% OwnerSSale−39.6K$27.32−$1.08M−0.2%17.1M after2 lots
Jun 2, 2023 (view filing)Jun 11 dayRice Steven J.Chief Administrative OfficerSSale−2.50K$25.67−$64.2K−2.3%106.8K after10b5-1
Jun 2, 2023 (view filing)Jun 11 dayRamasastry SairaDirectorSSale−3.50K$25.67−$89.8K−24.8%10.6K after10b5-1
May 25, 2023 (view filing)9:00 PM ETMay 23-242 daysSB Investment Advisers (UK) Ltd and 2 others10% OwnerSSale−274.5K$26.46−$7.26M−1.6%17.2M after6 lots
May 23, 2023 (view filing)9:00 PM ETMay 19-224 daysSB Investment Advisers (UK) Ltd and 2 others10% OwnerSSale−183.5K$25.55−$4.69M−1.0%17.5M after2 lots
May 9, 2023 (view filing)9:00 PM ETMay 54 daysSB Investment Advisers (UK) Ltd and 2 others10% OwnerSSale−136$25.10−$3.41K0.0%17.6M after
May 5, 2023 (view filing)9:00 PM ETMay 3-42 daysSB Investment Advisers (UK) Ltd and 2 others10% OwnerSSale−198.0K$25.53−$5.06M−1.1%17.6M after2 lots
May 3, 2023 (view filing)9:00 PM ETMay 12 daysSB Investment Advisers (UK) Ltd and 2 others10% OwnerSSale−3.08K$25.30−$77.8K0.0%17.8M after
Apr 26, 2023 (view filing)9:00 PM ETApr 24-252 daysSB Investment Advisers (UK) Ltd and 2 others10% OwnerSSale−67.0K$25.42−$1.70M−0.4%17.8M after2 lots
Apr 24, 2023 (view filing)9:00 PM ETApr 20-214 daysSB Investment Advisers (UK) Ltd and 2 others10% OwnerSSale−312.0K$25.76−$8.04M−1.7%17.9M after3 lots
Apr 20, 2023 (view filing)9:00 PM ETApr 18-192 daysSB Investment Advisers (UK) Ltd and 2 others10% OwnerSSale−83.1K$25.12−$2.09M−0.5%18.2M after2 lots
Apr 18, 2023 (view filing)9:00 PM ETApr 14-174 daysSB Investment Advisers (UK) Ltd and 2 others10% OwnerSSale−20.1K$25.08−$503.9K−0.1%18.3M after2 lots
Mar 31, 2023 (view filing)Mar 301 dayHanly Ann M.Chief Technology OfficerSSale−2.63K$22.77−$59.8K−2.2%114.6K after
Mar 9, 2023 (view filing)Mar 81 daySato Vicki LDirectorSSale−17.9K$22.59−$405.2K−1.3%1.33M after
Mar 7, 2023 (view filing)Mar 34 daysFriedl-Naderer JohannaEVP & Chief Operating OfficerSSale−1.48K$22.82−$33.8K−1.0%148.5K after
Mar 2, 2023 (view filing)Mar 11 daySigal Charles ElliottDirectorPPurchase+2.50K$22.73+$56.8K+33.3%10.0K after
Feb 28, 2023 (view filing)Feb 271 dayPang PhillipChief Medical OfficerSSale−10.3K$23.08−$238.1K−5.2%188.0K after2 lots
Feb 24, 2023 (view filing)Feb 231 dayHorn HowardCFOSSale−2.25K$25.97−$58.4K−1.0%230.7K after
Feb 24, 2023 (view filing)Feb 231 dayHanly Ann M.Chief Technology OfficerSSale−2.30K$25.97−$59.8K−1.9%117.2K after
Feb 24, 2023 (view filing)Feb 23-241 dayScangos George APresident and CEOSSale−27.8K$24.53−$680.8K−14.1%168.5K after3 lots
Feb 24, 2023 (view filing)Feb 231 dayPang PhillipChief Medical OfficerSSale−2.88K$25.97−$74.7K−1.4%198.3K after
Feb 24, 2023 (view filing)Feb 231 dayRice Steven J.Chief Administrative OfficerSSale−1.79K$25.97−$46.6K−1.6%108.4K after
Feb 23, 2023 (view filing)9:00 PM ETFeb 212 daysSB Investment Advisers (UK) Ltd and 2 others10% OwnerSSale−74.5K$28.43−$2.12M−0.4%18.3M after4 lots
Feb 21, 2023 (view filing)Feb 17-214 daysScangos George APresident and CEOSSale−27.8K$27.23−$755.6K−12.4%196.2K after3 lots
Feb 21, 2023 (view filing)Feb 174 daysRice Steven J.Chief Administrative OfficerSSale−1.98K$25.29−$50.1K−5.1%37.2K after
Feb 21, 2023 (view filing)Feb 174 daysPang PhillipChief Medical OfficerSSale−2.80K$25.29−$70.9K−1.9%141.2K after
Feb 21, 2023 (view filing)Feb 174 daysHorn HowardCFOSSale−2.42K$25.29−$61.3K−1.0%233.0K after